Detalles de la búsqueda
1.
Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
J Infect Dis
; 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38206187
2.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
J Med Virol
; 95(10): e29149, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805832
3.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
HIV Med
; 22(9): 843-853, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318591
4.
CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy.
Infection
; 49(5): 955-964, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963983
5.
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study.
AIDS Care
; 33(9): 1159-1166, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33172289
6.
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
J Antimicrob Chemother
; 75(1): 194-199, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605107
7.
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
J Antimicrob Chemother
; 74(3): 614-617, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476106
8.
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.
J Antimicrob Chemother
; 73(1): 177-182, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29077927
9.
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
J Antimicrob Chemother
; 78(7): 1808-1809, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220765
10.
Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy.
Infection
; 46(5): 693-699, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29766472
11.
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data.
Ann Pharmacother
; 52(8): 740-746, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29482352
12.
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.
BMC Infect Dis
; 17(1): 658, 2017 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28964268
13.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.
BMC Infect Dis
; 16(1): 401, 2016 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27515949
14.
Immunoglobulin M indirect-fluorescent antibody test for the diagnosis of acute toxoplasmosis during pregnancy in the avidity era: A 14-year experience at the Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy.
J Obstet Gynaecol Res
; 42(12): 1699-1703, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27762467
15.
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study).
New Microbiol
; 39(4): 290-294, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27551725
16.
Shall We Dance? Extending TANGO's Results to Clinical Practice.
Clin Infect Dis
; 71(7): e200-e201, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198516
17.
Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database.
Infection
; 43(3): 339-43, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25821204
18.
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice.
Int J Antimicrob Agents
; 63(1): 107040, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981074
19.
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
Microbes Infect
; : 105339, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38636822
20.
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy.
Int J Transgend Health
; 25(2): 268-282, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38681492